Moelis & Company (NYSE:MC) Shares Bought by nVerses Capital LLC

nVerses Capital LLC boosted its position in shares of Moelis & Company (NYSE:MC) by 110.0% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,300 shares of the asset manager’s stock after acquiring an additional 3,300 shares during the period. nVerses Capital LLC’s holdings in Moelis & Company were worth $432,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MC. Kayne Anderson Rudnick Investment Management LLC boosted its holdings in shares of Moelis & Company by 0.7% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 7,190,221 shares of the asset manager’s stock valued at $408,836,000 after buying an additional 47,365 shares in the last quarter. Wasatch Advisors LP boosted its holdings in shares of Moelis & Company by 4.9% in the 1st quarter. Wasatch Advisors LP now owns 3,417,643 shares of the asset manager’s stock valued at $194,020,000 after buying an additional 159,797 shares in the last quarter. Lord Abbett & CO. LLC boosted its holdings in shares of Moelis & Company by 5.2% in the 1st quarter. Lord Abbett & CO. LLC now owns 1,118,245 shares of the asset manager’s stock valued at $63,483,000 after buying an additional 55,402 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Moelis & Company by 4.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 755,541 shares of the asset manager’s stock valued at $42,960,000 after buying an additional 29,532 shares in the last quarter. Finally, Natixis Advisors LLC boosted its stake in Moelis & Company by 179.2% during the 2nd quarter. Natixis Advisors LLC now owns 708,140 shares of the asset manager’s stock worth $40,265,000 after purchasing an additional 454,478 shares during the period. Institutional investors and hedge funds own 91.53% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Wells Fargo & Company assumed coverage on shares of Moelis & Company in a research note on Thursday, September 12th. They set an “equal weight” rating and a $70.00 price target for the company. JPMorgan Chase & Co. increased their price target on shares of Moelis & Company from $50.00 to $51.00 and gave the stock a “neutral” rating in a research note on Thursday, July 25th. UBS Group increased their price target on shares of Moelis & Company from $54.00 to $60.00 and gave the stock a “sell” rating in a research note on Tuesday, October 8th. Morgan Stanley increased their price target on shares of Moelis & Company from $61.00 to $67.00 and gave the stock an “underweight” rating in a research note on Monday, September 23rd. Finally, Keefe, Bruyette & Woods reiterated a “market perform” rating and set a $60.00 price target (up previously from $54.00) on shares of Moelis & Company in a research note on Thursday, July 25th. Two investment analysts have rated the stock with a sell rating and six have given a hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $61.00.

Insider Activity

In other news, CFO Joseph Simon sold 6,723 shares of the stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $64.00, for a total value of $430,272.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CFO Joseph Simon sold 6,723 shares of the stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $64.00, for a total value of $430,272.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Kenneth Shropshire sold 495 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $69.29, for a total transaction of $34,298.55. Following the completion of the sale, the director now directly owns 9,372 shares in the company, valued at approximately $649,385.88. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 12,526 shares of company stock worth $830,133 in the last 90 days. 6.40% of the stock is currently owned by corporate insiders.

Moelis & Company Stock Performance

Shares of Moelis & Company stock opened at $71.90 on Friday. The company has a market cap of $5.38 billion, a P/E ratio of -378.42 and a beta of 1.33. Moelis & Company has a one year low of $38.58 and a one year high of $72.80. The firm has a fifty day moving average of $66.76 and a two-hundred day moving average of $60.16.

Moelis & Company (NYSE:MC) last announced its quarterly earnings data on Wednesday, July 24th. The asset manager reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.07. The company had revenue of $264.59 million during the quarter, compared to the consensus estimate of $227.90 million. Moelis & Company had a net margin of 1.38% and a return on equity of 4.38%. Moelis & Company’s quarterly revenue was up 47.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.04) EPS. As a group, equities analysts predict that Moelis & Company will post 1.08 earnings per share for the current year.

Moelis & Company Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 26th. Stockholders of record on Monday, August 5th were issued a $0.60 dividend. The ex-dividend date of this dividend was Monday, August 5th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 3.34%. Moelis & Company’s dividend payout ratio is presently -1,263.16%.

Moelis & Company Company Profile

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.